Drug Type Small molecule drug |
Synonyms |
Mechanism CACNA2D1 modulators(Voltage-gated calcium channel alpha2/delta subunit 1 modulators), calcium channel inhibitors(Calcium Channel inhibitors), μ opioid receptor agonists(Mu opioid receptor agonists) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingClinical |
First Approval Date- |
Regulation- |
Molecular FormulaC25H45ClMgN2O8S |
InChIKeyAZQAEECQTYCGKX-VGRVZHFZSA-N |
CAS Registry1371629-04-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetic Neuropathies | Phase 1 | US | - |